Grown Rogue International (GRUSF) Long-Term Investments (2020 - 2026)
Grown Rogue International's (GRUSF) quarterly Long-Term Investments came in at $1.5 million in Q1 2026, down 15.69% year-on-year from $1.7 million in Q1 2025, and up 7.38% quarter-over-quarter from $1.4 million in Q4 2025.
Grown Rogue International (GRUSF) Long-Term Investments (2020 - 2026) Analysis & Trends
Grown Rogue International's Long-Term Investments history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- On a quarterly basis, Long-Term Investments fell 15.69% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 15.69% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, up 135.93% from the prior year.
- Long-Term Investments advanced to $1.5 million in Q1 2026 per GRUSF's latest filing, from $1.4 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $2463.2 billion in Q3 2025 and bottomed at -$211041.0 in Q3 2023.
- The 4-year median for Long-Term Investments is $1.5 million (2026), against an average of $273.7 billion.
- Across the five-year window, Long-Term Investments soared 232394022.7% in 2025 and decreased 15.69% in 2026, its largest moves.
- Year by year, Long-Term Investments stood at -$211041.0 in 2023, then soared by 372.92% to $575967.0 in 2024, then surged by 135.93% to $1.4 million in 2025, then rose by 7.38% to $1.5 million in 2026.
- Per Business Quant, the three latest GRUSF Long-Term Investments figures stand at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $2463.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 2,463.22 Bn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 575,967.00 |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jul 31, 2023 | -211,041.00 |
| Oct 31, 2021 | -750,000.00 |
| Jul 31, 2021 | -750,000.00 |
| Apr 30, 2021 | 1.45 Mn |
| Jan 31, 2021 | 189,915.00 |
| Oct 31, 2020 | 187,812.00 |
| Jul 31, 2020 | 162,812.00 |
| Apr 30, 2020 | -150,000.00 |